Yes, this is a well-researched combination where Thymosin Alpha-1 modulates immune system balance while BPC-157 repairs tissue damage and reduces inflammation. This stack is particularly studied in inflammatory bowel conditions where both immune dysregulation and tissue damage occur. Research in
Expert Opinion on Biological Therapy demonstrates complementary mechanisms with Thymosin Alpha-1 normalizing T-cell function and BPC-157 promoting mucosal healing.